Strategies to reduce use of antidepressants
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Antidepressant prescribing has increased year on year since the introduction of the selective serotonin reuptake inhibitors (SSRIs) in the 1980s. More than 10% of adults in England are now taking antidepressants for depression/anxiety, with a median length of treatment of more than 2 years, but antidepressants can cause side effects and withdrawal symptoms which increase with longer use. Surveys of antidepressant users suggest 30–50% have no evidence‐based indication to continue, but coming off antidepressants is often difficult due to fears of relapse, withdrawal symptoms and a lack of psychological treatments to replace maintenance treatment and prevent relapse. GPs should not prescribe antidepressants routinely for mild depressive/anxiety symptoms. Patients starting antidepressants should be advised that they are to be taken for a limited period only, and that there is a risk of withdrawal problems on stopping them. Prescribers should actively review long‐term antidepressant use and suggest coming off them slowly to patients who are well. The relationship between SSRI dose and serotonin transporter receptor occupancy suggests that hyperbolic tapering regimes may be helpful for patients with troubling withdrawal symptoms who cannot stop treatment within 4–8 weeks, and tapering strips can allow carefully titrated slower dose reduction over some months. Internet and telephone support to patients wanting to reduce their antidepressants is being trialled in the REDUCE programme. More research is needed to establish the incidence of withdrawal symptoms in representative samples of patients coming off antidepressants, and large randomised controlled trials are needed to test different tapering strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 2×
“pressants are appropriate for some patients to reduce the risk of relapse.(26,27) The National Institute for Health and Care Excellence (NICE) recommends treating people for 2 years in the first instance if”
BackgroundAntidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833 · cited 3×
“sants could account for some of the associations between them and the adverse outcomes.(16) In up to a half of patients, long-term treatment may blunt their ability to feel emotions.”
BackgroundInfluentialMindfulness-based cognitive therapy to prevent relapse in recurrent depression.
Kuyken, W., Byford, S., Taylor, R. S., Watkins, E., Holden, E., White, K., Barrett, B., Byng, R., Evans, A., Mullan, E., et al. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0013786 · Cited by 770
SSRI Antidepressant Medications: Adverse Effects and Tolerability
Ferguson, J. M. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0105 · Cited by 669 · cited 1×
“The SSRIs frequently cause significant weight change, sleep disturbance and sexual dysfunction.(15) Anti-”
BackgroundPatient Barriers to and Enablers of Deprescribing: a Systematic Review
Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M. S., & Wiese, M. D. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0106-8 · Cited by 536 · cited 1×
“Psychological therapies may work by providing support to patients to manage fears of withdrawal, relapse and lack of selfefficacy, which are possible barriers to discontinuation.(64) 28 KENDRICK”
BackgroundPrevention of Recurrent Depression With Cognitive Behavioral Therapy: Preliminary Findings
Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.9.816 · Cited by 491
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436 · cited 1×
“Anxiety, mood swings and sleep disturbance may appear to be a recurrence of the original problem requiring treatment.(20) Restarting medication, before withdrawal”
BackgroundSix-Year Outcome of Cognitive Behavior Therapy for Prevention of Recurrent Depression
Fava, G. A., Ruini, C., Rafanelli, C., Finos, L., Conti, S., & Grandi, S. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1872 · Cited by 392 · cited 1×
“showed significantly lower risks of recurrence with CBT and tapering vs clinical management and tapering after 2 years (15% vs 35% and 25% vs 80% respectively),(50,57,58) and after 6 years (40% vs 75% and 50% vs 90% respectively).(50,59,60) Meta-analysis of two studies by Kuyken et al.”
ResultDavies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387
Research works printed but not linked: 29
- 10.1136/bmj.f7261 · DOI
- Taylor S, 2019, Dependence and Withdrawal Associated with Some Prescribed Medicines: An Evidence Review
- 10.1007/s00228-004-0726-3 · DOI
- 10.1192/bjp.bp.115.166975 · DOI · Paper page
- 10.1016/j.jad.2015.03.040 · DOI
- Spence R, 2014, Antidepressant Prescribing: Trends in the Prescribing of Antidepressants in Primary Care
- 10.1136/bmj.f191 · DOI · Paper page
- Pratt LA, 2011, Antidepressant use in persons aged 12 and over: United States, 2005–2008, NCHS Data Brief, 76, 1
- Middleton DJ, 2011, Continuity and monitoring of antidepressant therapy in a primary care setting, Qual Prim Care, 19, 109
- 10.1093/fampra/cmu019 · DOI
- 10.1136/bmj.g228 · DOI
- Cruickshank G, 2008, Cross‐sectional survey of patients in receipt of long‐term repeat prescriptions for antidepressant drugs in primary care, Ment Health Fam Med, 5, 105
- EveleighRH.Inappropriate long‐term antidepressant use in primary care: a challenge to change (PhD thesis). Nijmegen: Radboud University;2015.
- ManginD DowsonC MulderR et al.The effectiveness of maintenance SSRI treatment in primary care depression to prevent recurrence: multicentre double blinded placebo controlled RCT. Proceedings of the 2015 North American Primary Care Research Group (NAPCRG) 43rd Annual Meeting.
- 10.1192/bjp.bp.111.104257 · DOI · Paper page
- McCrone P, 2008, Paying the Price: The Cost of Mental Health Care in England to 2026, 15
- 10.1001/archinte.166.10.1092 · DOI · Paper page
- 10.3399/bjgp18X695681 · DOI
- 10.1016/j.jad.2015.06.052 · DOI
- 10.3399/bjgp09X454061 · DOI
- Groot PC, 2013, Taperingstrips voor paroxetine en venlafaxine, Tijdschr Psychiatr, 55, 789
- 10.1080/17522439.2018.1469163 · DOI · Paper page
- 10.3310/hta19730 · DOI · Paper page
- 10.1192/bjp.bp.115.168971 · DOI · Paper page
- 10.3399/bjgp13X671641 · DOI
- 10.1186/s13063-020-04338-7 · DOI · Paper page
- 10.1136/bmjopen-2019-032312 · DOI
- 10.1093/nar/gkx1121 · DOI · Paper page
- 10.1111/bph.13883 · DOI · Paper page
Cited by
White, E., Read, J., & Julo, S. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320981174 · Cited by 63
Amrein, M. A., Hengartner, M. P., Näpflin, M., Farcher, R., & Huber, C. A. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03559-4 · Cited by 23
“However, recent literature indicates that a higher number of AD prescriptions is mainly due to a higher number of long-term users [11, 12].”
BackgroundMunro, N. R., Teague, S., Somoray, K., Simpson, A., Budden, T., Jackson, B., Rebar, A., & Dimmock, J. (2026) · British Journal of Sports Medicine · doi:10.1136/bjsports-2025-110301 · Cited by 23
Metadata
- Authors
- Kendrick, T.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2020-07-27
- Volume
- 87
- Issue
- 1
- Pages
- 23-33
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W3040894952
- Cited by
- 96
- References
- 38
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Funders
- Programme Grants for Applied Research (RP‐PG‐1214‐20004)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Strategies to reduce use of antidepressants. https://app.cochat.ai/papers/10.1111/bcp.14475
- The paper
- Kendrick, T. (2021). Strategies to reduce use of antidepressants. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.14475
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.